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Abstract
Pulmonary inflammation contributes to ventilator-induced lung injury. Sepsis-induced pulmonary inflammation (first hit)
may be potentiated by mechanical ventilation (MV, second hit). Electrical stimulation of the vagus nerve has been shown to
attenuate inflammation in various animal models through the cholinergic anti-inflammatory pathway. We determined the
effects of vagotomy (VGX) and vagus nerve stimulation (VNS) on systemic and pulmonary inflammation in a two-hit model.
Male Sprague-Dawley rats were i.v. administered lipopolysaccharide (LPS) and subsequently underwent VGX, VNS or a sham
operation. 1 hour following LPS, MV with low (8 mL/kg) or moderate (15 mL/kg) tidal volumes was initiated, or animals
were left breathing spontaneously (SP). After 4 hours of MV or SP, rats were sacrificed. Cytokine and blood gas analysis was
performed. MV with 15, but not 8 mL/kg, potentiated the LPS-induced pulmonary pro-inflammatory cytokine response
(TNF-a, IL-6, KC: p,0.05 compared to LPS-SP), but did not affect systemic inflammation or impair oxygenation. VGX
enhanced the LPS-induced pulmonary, but not systemic pro-inflammatory cytokine response in spontaneously breathing,
but not in MV animals (TNF-a, IL-6, KC: p,0.05 compared to SHAM), and resulted in decreased pO2 (p,0.05 compared to
sham-operated animals). VNS did not affect any of the studied parameters in both SP and MV animals. In conclusion, MV
with moderate tidal volumes potentiates the pulmonary inflammatory response elicited by systemic LPS administration. No
beneficial effects of vagus nerve stimulation performed following LPS administration were found. These results questions
the clinical applicability of stimulation of the cholinergic anti-inflammatory pathway in systemically inflamed patients
admitted to the ICU where MV is initiated.
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Introduction
Patients with severe sepsis and septic shock often suffer from
respiratory failure, placing them in need of mechanical ventilation
(MV). While this intervention is lifesaving, MV can lead to, or
worsen lung injury; a condition called ventilator-induced lung
injury (VILI) [1]. MV-induced cyclic stretch and/or overinflation
elicits a pulmonary inflammatory response (biotrauma) character-
ized by cytokine production, neutrophil recruitment and lung
edema, resulting in impaired lung function [2,3]. Patients with
systemic inflammation, such as in sepsis, are at increased risk for
developing VILI [4]. It is thought that the additional inflammatory
insult, or second ‘hit’ induced by MV, synergizes with the
underlying systemic inflammatory process, resulting in detrimental
effects on the lungs and other organs (multiple-hit theory) [5,6].
This cascade of events can ultimately lead to multiple organ
dysfunction syndrome (MODS), associated with high mortality [7].
In clinical practice, treatment aimed to limit the initial
overwhelming systemic pro-inflammatory state in sepsis has not
proved very successful [8]. However, limiting the second
inflammatory hit caused by MV may represent a viable therapy
to reduce lung injury and subsequent multi-organ failure in
systemically inflamed patients.
Recently, it was demonstrated that the vagus nerve can
reflexively limit the innate immune response via binding of its
neurotransmitter acetylcholine to the a7 nicotinic acetylcholine
receptor (a7nAChR) present on macrophages [9,10]. This
mechanism was named ‘the cholinergic anti-inflammatory path-
way’. Electrical stimulation of the vagus nerve has shown to
attenuate inflammation and improve outcome in several animals
models [11–13]. However, this pathway has been relatively
sparsely studied in VILI. We have recently shown that pre-
treatment with the selective a7nAChR agonist GTS-21 amelio-
rates VILI in mice [14]. In addition, two very recent investigations
demonstrated that electrical vagus nerve stimulation attenuates
VILI induced by injurious tidal volumes [15], and in a two-hit
model (hemorrhagic shock followed by MV) [16], while transec-
tion of the vagus nerve (vagotomy) resulted in worse outcome [16].
However, in these studies, stimulation or ablation of the
cholinergic anti-inflammatory pathway was performed before the
initial insult [14,15], or twice, before the first and second insult
[16], thereby limiting its clinical applicability.
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In the present study we investigated the effects of vagus nerve
stimulation and vagotomy on systemic and pulmonary inflamma-
tion using a two-hit model in rats. We used lipopolysaccharide
(LPS) administration as the first and MV using low and moderate
tidal volumes as the second hit, to model the sepsis patient that is
admitted to the ICU in a hyperinflammatory state where MV is
initiated. As mitigating the initial pro-inflammatory hit is often not
possible in clinical practice, we applied vagus nerve stimulation or
vagotomy after LPS administration and before the start of
mechanical ventilation.
Materials and Methods
Reagents
Lipopolysaccharide (LPS, derived from E. coli, serotype
0111:B4) was obtained from Sigma-Aldrich (St Louis, MO,
USA) and was dissolved in 0.9% NaCl. The LPS solution was
sonicated for a minimum of 30 minutes prior to use. Alfaxalone
was purchased from Ve´toquinol (Buckingham, UK).
Animals
All procedures described were in accordance with the
requirements of the Dutch Experiments on Animals Act, the EC
Directive 86/609 and approved by the Animal Ethics Committee
of the Radboud University Nijmegen Medical Center (permit
no. RU-DEC 2010-068). Male Sprague-Dawley rats (Charles
River, Sutzfield, Germany) weighing 300–450 gram were used in
all experiments. All surgery was performed under alfaxalone
anesthesia, and all efforts were made to minimize suffering.
Experimental protocol
The tail vein was cannulated for anesthesia induction and
maintenance. Anesthesia was induced by infusion of alfaxalone
(15 mg/kg) and maintained by continuous infusion of 33 mg/kg/
hour alfaxalone throughout the experiment. The right femoral
artery was cannulated to allow continuous blood pressure
monitoring, Ringer’s lactate administration (5 mL/kg/hour,
containing 4 IE/ml heparin) and blood sampling. LPS (10 mg/
kg) or placebo (0.9% NaCl) was administered via the tail vein
(time-point T=21). Next, a cervical midline incision was made
and the left vagus nerve was exposed. In sham-animals (SHAM),
the wound was covered with moist gauze for 10 minutes. In vagus
nerve stimulation animals (VNS), the vagus nerve was prepared
free from the carotid artery and, without transecting the nerve,
placed on a bipolar platinum electrode (Plastics One, Roanoke,
VA, USA) connected to a Grass S11 stimulator with a SIU5
stimulus isolation unit. The nerve was stimulated for 3 minutes at
5 V, 5 Hz, 2 ms [17,18]. In vagotomy animals (VGX), both the
left and right vagus nerves were transected (bilateral vagotomy).
Subsequently, rats were tracheotomized with and the tracheal
cannula was fixed with ligatures. Animals were left spontaneously
breathing using a nose cone supplying air with an FiO2 of 40%
until 1 hour after LPS/placebo administration when mechanical
ventilation (MV) was started (T=0). Animals were ventilated using
a Ugo Basile UB7025 ventilator (Hugo Sachs Elektronik-Harvard
Apparatus, March-Hugstetten, Germany). Ventilation parameters:
tidal volume 8 or 15 mL/kg, frequency 75 (8 mL/kg) or 40
(15 mL/kg) breaths/min, PEEP 1 cmH2O, FiO2 40%. Sponta-
neously breathing (SP) animals were not connected to the
ventilator but continued breathing air with an FiO2 of 40% using
a nose cone. Rectal temperature was monitored throughout the
experiment and was kept between 36.5uC and 37.5uC using a
heating pad and blankets. All animals were sacrificed by
exsanguination after 4 hours of mechanical ventilation/spontane-
ous breathing (T= 4). The experimental protocol is illustrated in
Figure 1.
Blood gas and cytokine measurements
Blood gas parameters pH, pO2, pCO2, BE, HCO3 and lactate
were determined with an i-STAT Blood Gas Analyzer (Abbot,
Hoofddorp, the Netherlands). EDTA anticoagulated blood was
centrifuged for 5 minutes at 14000 rpm and plasma was stored at
280uC until analysis by a simultaneous Luminex assay (Milliplex,
Billerica, MA, USA) according to the manufacturer’s instructions.
Immediately after exsanguination, the lungs were carefully
removed. The upper part of the left lung was snap-frozen in
liquid nitrogen and stored at 280uC until analysis. Lungs were
homogenized in T-PER (Thermo Fisher Scientific, Rockford, IL,
USA) supplemented with protease inhibitor (complete EDTA-free
tablets, Roche, Woerden, The Netherlands) in M-Tubes using a
GentleMACS dissociater (protein_01 program, Miltenyi Biotec,
Utrecht, The Netherlands). M-tubes with homogenates were
centrifuged (4000 g, 5 min, 4uC), after which the supernatant was
transferred to an eppendorf tube and centrifuged again (14000 g,
10 min, 4uC). Cytokines in supernatants were measured by ELISA
(Duoset, R&D systems, Minneapolis, MN, USA) according to the
manufacturer’s instructions.
Figure 1. Experimental procedures.
doi:10.1371/journal.pone.0034431.g001
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Statistical Analysis
Data are expressed as mean6SEM. The Grubbs test (extreme
studentized deviate method) was performed and significant outliers
were excluded from analysis (maximum of one exclusion per
dataset). Statistical differences between groups were detected by
one-way ANOVA with Bonferroni post-hoc test. A p-value less
than 0.05 was considered statistically significant. All tests were
performed with Graphpad Prism 5 (Graphpad Software, La Jolla,
USA).
Results
MV with 8 mL/kg does not elicit an inflammatory
response, nor does it amplify the LPS-induced
inflammatory response
Compared to spontaneously breathing animals, MV with a tidal
volume of 8 mL/kg did not result in an increase in pulmonary
levels of the pro-inflammatory cytokine TNF-a or the anti-
inflammatory cytokine IL-10 (Figure 2). LPS administration in
spontaneously breathing animals significantly increased pulmo-
nary cytokine levels. However, MV did not enhance the LPS–
induced cytokine response (Figure 2). A similar pattern was
observed for other pro-inflammatory cytokines (IL-6 and KC,
data not shown). MV did not result in increased levels of
plasma cytokines (Figure 3). As expected, LPS administration
resulted in high plasma cytokine levels, however, similar to the
lung data, MV did not further increase or sustain cytokine
levels. Again, this pattern was similar for IL-6 and KC (data
not shown).
In placebo-treated animals, MV resulted in increased pH and
decreased pCO2 compared to spontaneously breathing animals
(Table 1). LPS administration resulted in significantly lower
arterial blood pressure compared to placebo in both spontaneously
breathing and MV animals. Furthermore, the increase in pH
observed upon ventilation in placebo-treated animals was not
present in LPS-treated animals. In spontaneously breathing rats,
LPS administration resulted in lower pCO2 levels compared to
placebo, probably as a result of inflammation-induced hyperven-
tilation. No differences in oxygenation were observed between any
of the groups.
Figure 2. Effects of ventilation with 8 mL/kg in LPS- or placebo-pretreated rats on pulmonary inflammation. Pulmonary concentrations
of pro-(A: TNF-a) and anti-inflammatory (B: IL-10) cytokines in placebo- and LPS-treated spontaneously breathing and mechanically ventilated (MV,
8 mL/kg) rats. Pulmonary cytokine levels are normalized to the total amount of protein in each lung homogenate. Data are represented as mean 6
SEM of 8–9 animals per group. * indicates p,0.05, one-way ANOVA with Bonferroni post-hoc test.
doi:10.1371/journal.pone.0034431.g002
Figure 3. Effects of ventilation with 8 mL/kg in LPS- or placebo-pretreated rats on systemic inflammation. Plasma concentrations of
pro-(A: TNF-a) and anti-inflammatory (B: IL-10) cytokines in placebo- and LPS-treated spontaneously breathing (SP) and mechanically ventilated (MV,
8 mL/kg) rats. Data are represented as mean 6 SEM of 8–9 animals per group. * indicates p,0.05 between placebo- and LPS-treated groups (one-
way ANOVA with Bonferroni post-hoc test). There were no differences between the placebo-SP and placebo-MV or the LPS-SP and LPS-MV groups.
doi:10.1371/journal.pone.0034431.g003
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MV with 15 mL/kg does not elicit an inflammatory
response, but amplifies the LPS-induced pulmonary
inflammatory response
Similar to MV with 8 mL/kg, a tidal volume of 15 mL/kg did
not result in pulmonary cytokine production (TNF-a shown in
Figure 4A). LPS administration in spontaneously breathing
animals significantly increased pulmonary cytokine levels, and
MV significantly enhanced LPS–induced pro-inflammatory (TNF-
a, IL-6 and KC; TNF-a shown in Figure 4A) but not anti-
inflammatory (IL-10) pulmonary cytokine levels. MV with 15 mL/
kg did not result in increased plasma cytokine levels (data not
shown). Similar to the data presented in Figure 3, LPS
administration resulted in high plasma cytokine levels, however,
MV did not affect plasma cytokine levels (data not shown).
At T= 0 and T=2 (1 and 3 hours post-administration), both
spontaneously breathing and ventilated rats treated with LPS
displayed a significantly lower blood pressure compared with
placebo-treated ventilated animals (Table 2). At T=4, blood
pressure was restored in LPS-treated spontaneously breathing rats,
but still significantly decreased in LPS-MV rats. pH was
significantly lower and pCO2 significantly higher in spontaneously
breathing LPS-treated rats compared with the other groups.
Compared with placebo-treated ventilated animals, oxygenation
was significantly lower in LPS-treated spontaneously breathing
animals. However, no difference in oxygenation between LPS-
treated ventilated animals and placebo-treated ventilated animals
was found.
Vagotomy enhances pulmonary inflammation and
impairs oxygenation in spontaneously breathing, but not
in ventilated (15 mL/kg) rats
Vagotomy resulted in significantly increased pulmonary levels of
all pro-inflammatory cytokines in LPS-treated spontaneously
breathing animals compared with sham-operated or vagus
nerve-stimulated rats (TNF-a depicted in Figure 4B). IL-10 was
not affected by vagotomy (data not shown). Furthermore,
vagotomy exerted no effects in ventilated rats (Figure 4B). Plasma
cytokine levels were not affected by vagotomy in spontane-
ously breathing or ventilated LPS-treated animals (data not
shown). In ventilated animals, no effects of vagotomy on blood
pressure or blood gas parameters were found (data not shown).
However, in spontaneously breathing rats, vagotomy resulted
in significantly lower blood pressure at T= 0 and lower pO2
levels at T= 0 and T=2 compared to sham-operated animals
(Table 3). Vagus nerve stimulation affected neither pulmonary
(TNF-a depicted in Figure 4B) or plasma cytokine levels (data
not shown), nor blood gas parameters in both spontaneously
breathing (Table 3) and ventilated LPS-treated animals (data not
shown).
Table 1. Cardiorespiratory parameters in placebo and LPS-
treated (10 mg/kg) rats ventilated with 8 ml/kg or left
breathing spontaneously.
Parameter group T=21 T=0 T=2 T=4
MAP placebo-SP 13362 9864a 10068b 11568d
LPS-SP 12863 7165a 8264 7366d
placebo-MV 12465 9764 12867b,c 12569e
LPS-MV 13363 8166 9163c 8966e
pH placebo-SP 7.3660.01 7.3160.01 7.3660.02f 7.4060.01h
LPS-SP 7.3660.01 7.3360.02 7.3560.02 7.4060.02
placebo-MV 7.3460.02 7.2960.01 7.4960.01f,g 7.4960.02h,i
LPS-MV 7.3660.01 7.3160.01 7.4060.01g 7.4060.02i
pCO2 placebo-SP 5963 6863
j 6464l,m 5763n,o
LPS-SP 5965 5263j 5163l 4464n
placebo-MV 6263 7264k 3862m 3861o
LPS-MV 5861 5762k 4363 4364
pO2 placebo-SP 149616 122610 113610 11069
LPS-SP 142610 126612 117610 10868
placebo-MV 161610 13467 12667 12266
LPS-MV 139611 14169 13069 11365
LPS/placebo administered at T =21, mechanical ventilation (MV) started at
T = 0. MAP: mean arterial pressure, SP: spontaneously breathing. Data are
represented as mean 6 SEM of 8–9 animals per group. Superscript character
pairs indicate p,0.05, one-way ANOVA with Bonferroni post-hoc test.
doi:10.1371/journal.pone.0034431.t001
Figure 4. Effects of ventilation with 15 mL/kg in LPS- or placebo-pretreated rats, and vagus nerve stimulation/vagotomy on
pulmonary inflammation. A: Pulmonary concentrations of TNF-a in placebo- and LPS-treated spontaneously breathing (SP) and mechanically
ventilated (MV, 8 or 15 mL/kg) rats. B: Pulmonary concentrations of TNF-a in LPS-treated spontaneously breathing and mechanically ventilated
(15 mL/kg) rats that underwent a sham operation (SHAM), bilateral vagotomy (VGX) or vagus nerve stimulation (STM). Pulmonary cytokine levels are
normalized to the total amount of protein in each lung homogenate. Data are represented as mean 6 SEM of 6–8 animals per group. * indicates
p,0.05, one-way ANOVA with Bonferroni post-hoc test.
doi:10.1371/journal.pone.0034431.g004
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Discussion
In this study, we show that mechanical ventilation with
moderate, but not with low tidal volumes potentiates the
pulmonary inflammatory response elicited by systemic LPS
administration. Vagotomy applied after LPS administration
resulted in amplification of the LPS-induced pulmonary inflam-
matory response and reduced oxygenation in spontaneously
breathing animals. However it did not affect inflammatory or
respiratory parameters in ventilated rats. Vagus nerve stimulation
performed after LPS administration had no effects in either
ventilated or spontaneously breathing rats.
In the absence of LPS, MV with low (8 mL/kg) or moderate
(15 mL/kg) tidal volumes did not result in a pulmonary or
systemic inflammatory response. In contrast, we [14,19] and
others [20] have recently shown that 4–5 hours of MV with
8 mL/kg in mice results in increased levels of inflammatory
cytokines in both lungs and plasma. It appears that rats are less
susceptible to MV-induced pulmonary inflammation. For in-
stance, 4-hour ventilation with 8 mL/kg did not result in increased
levels of pulmonary cytokines or neutrophils [6]. Even MV with
24 mL/kg did not lead to increased wet/dry ratios or impaired
oxygenation, while only moderate increases in pulmonary
inflammation were found [6]. This probably accounts for the
common use of very high tidal volumes (.30 cmH2O) in rat VILI
models that hinder interpretation with regard to the human
situation [21–23]. These findings signify that there are large
interspecies differences with regard to the inflammatory response
to MV. With respect to humans, a recent study in ARDS patients
demonstrated that lowering of tidal volumes from 6.3 to 4.2 mL/
kg accompanied by extracorporeal carbon dioxide removal was
associated with a significant decrease in inflammatory mediators in
bronchoalveolar lavage fluid [24], suggesting that there is no clear
cutoff value for safe tidal volumes in humans.
The second hit, MV, potentiated the first hit induced by
systemic LPS administration with regard to pulmonary inflamma-
tion, but only when a moderately high tidal volume of 15 mL/kg
was used. This tidal volume might still be clinically relevant in light
of the partially collapsed or fluid-filled ‘baby lungs’ [25] observed
in septic patients with lung injury of which only a portion is
ventilated [16]. We chose to start MV one hour after LPS
administration. At this time-point, high plasma concentrations of
TNF-a, an important cytokine in the pathophysiology of VILI
[26], are found. Using this approach, we attempted to simulate a
patient with systemic hyperinflammation admitted to the ICU for
initiation of mechanical ventilation. While we did find increased
levels of all pro-inflammatory cytokines in lungs of LPS-treated
ventilated animals compared with LPS-treated spontaneously
breathing rats, we could not demonstrate a statistically significant
impaired gas exchange. In this respect, our two-hit model does not
represent a true lung injury model. The direct interaction of
systemic LPS administration and MV has been scarcely studied.
The most commonly used two-hit models employ intratracheal
LPS administration or hemorrhagic shock followed by MV
[16,27–29]. Both of these treatments are expected to have a more
severe effect on lung function compared with systemic LPS
administration which might explain the lack of an effect on gas
exchange in our study. In a rat study where LPS was also i.v.
administered one hour before the start of 4-hour MV, increased
lung inflammation and injury was found in LPS-treated ventilated
rats compared with non-ventilated non-LPS-treated rats [30].
Unfortunately, no spontaneously breathing LPS-treated or
placebo-treated MV groups were studied for comparison [30].
Two similar studies in rabbits have investigated direct interactions
between systemic LPS and MV using moderate tidal volumes (10–
15 mL/kg) [31,32]. However, in these studies, LPS was admin-
istered 2 hours after the start of a 6–8 hour MV period.
Nevertheless, the authors did find impaired oxygenation, altered
histopathological lung alterations and reduced compliance in LPS-
treated MV animals compared with a spontaneously breathing
LPS-treated group or placebo-treated MV group. In line with our
results, these studies also demonstrated that MV potentiates the
pulmonary, but not systemic inflammatory response to i.v. LPS
administration [31,32].
Table 2. Cardiorespiratory parameters in placebo and LPS-
treated (10 mg/kg) sham-operated rats ventilated with 15 ml/
kg or left breathing spontaneously.
Parametergroup T=21 T=0 T=2 T=4
MAP placebo-MV 9666 11365a,b 12866c,d 11365e
LPS-SP 10260 9266a 10265c 10265
LPS-MV 10262 9064b 9264d 8166e
pH placebo-MV 7.3560.03 7.3260.03 7.5860.01f 7.5560.02h
LPS-SP 7.3760.01 7.3360.02 7.3460.01f,g 7.4060.02h,i
LPS-MV 7.3460.01 7.3260.01 7.5460.03g 7.5360.03i
pCO2 placebo-MV 6365 6866 3061
j 3262l
LPS-SP 6163 6063 5763j,k 5163l,m
LPS-MV 6563 5863 3068k 3062m
pO2 placebo-MV 144622 139615 19863
n 19965o
LPS-SP 133617 16463 14364n 13563o
LPS-MV 182620 162613 172621 166622
LPS/placebo administered at T =21, mechanical ventilation (MV) started at
T = 0. MAP: mean arterial pressure, SP: spontaneously breathing. Data are
represented as mean 6 SEM of 6 animals per group. Superscript character pairs
indicate p,0.05, one-way ANOVA with Bonferroni post-hoc test.
doi:10.1371/journal.pone.0034431.t002
Table 3. Cardiorespiratory parameters in LPS-treated (10 mg/
kg) spontaneously breathing rats that underwent a sham
operation, vagotomy, or vagus nerve stimulation.
Parametergroup T=21 T=0 T=2 T=4
MAP SHAM 10260 9266a 10265 10265
VGX 10166 7462a 10365 9968
STM 9664 8765 9967 9169
pH SHAM 7.3760.01 7.3360.02 7.3460.01 7.3960.02
VGX 7.3860.03 7.3360.02 7.3660.02 7.3860.01
STM 7.3760.02 7.3260.02 7.3360.03 7.4060.02
pCO2 SHAM 6163 6063 5763 5163
VGX 5766 5463 4861 4862
STM 5964 5963 5864 4964
pO2 SHAM 133617 16463
b 14364c 13563
VGX 124620 116613b 93611c 10564
STM 124622 147614 128611 118613
LPS administered at T =21. MAP: mean arterial pressure, SHAM: sham
operation, VGX: vagotomy, STM: vagus nerve stimulation. Data are represented
as mean 6 SEM of 6 animals per group. Superscript character pairs indicate
p,0.05, one-way ANOVA with Bonferroni post-hoc test.
doi:10.1371/journal.pone.0034431.t003
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Our result partly corroborate previously described findings of
increased pulmonary inflammation after vagotomy [16]. In
spontaneously breathing rats, vagotomy enhanced LPS-induced
pulmonary inflammatory cytokine levels and was associated with
impaired oxygenation, suggestive of a direct inhibitory effect of the
vagus nerve on pulmonary cytokine production. However, no
effects were observed in LPS-treated MV rats. These seemingly
contradictory results have led us to formulate an alternative
hypothesis. Pulmonary stretch receptors play an important role in
mediating information on lung mechanics via the afferent vagus
nerve, and it was recently shown that inhibition of afferent vagus
nerve signaling by cooling resulted in increased tidal volumes [33].
Therefore, it could be speculated that, in our experiments,
vagotomy abrogated the pulmonary stretch receptor-feedback
mechanism, leading to increased, injurious tidal volumes and
subsequent elevated pulmonary cytokine levels in spontaneously
breathing animals. In this regard, it is of note that in our
experiments, a clearly noticeable change in breathing pattern was
observed after bilateral vagotomy. This would also explain why no
effects of vagotomy on pulmonary cytokine production were
observed in mechanically ventilated rats, where breathing pattern
and tidal volume were controlled by the ventilator.
It was recently demonstrated that vagus nerve stimulation
attenuates the pulmonary inflammatory response and improves
oxygenation in rats subjected to hemorrhagic shock and
subsequent ventilation with 12 mL/kg for 4 hours [16]. In
contrast, we found no effects of vagus nerve stimulation on any
of the studied parameters. One might argue that we have
stimulated the nerve for a too short period (3 minutes). This
appears not to be a plausible explanation however, as in mice, the
anti-inflammatory effects of vagus nerve stimulation were equal
whether it was performed for 0.5, 2 or 20 minutes [18]. Therefore,
the lack of an effect is likely due to the timing of the intervention.
In the aforementioned study, vagus nerve stimulation was
performed prior to induction of hemorrhagic shock, hence before
the ‘first hit’ [16]. We stimulated the vagus nerve following the first
hit but before initiation of MV; in our view a more clinically
relevant time-point. The inflammatory cascade induced by LPS
administration might have been too far advanced for vagus nerve
stimulation to limit it. However, this does not explain why
stimulation did not attenuate the MV-induced increase in
pulmonary inflammation elicited by LPS. Nevertheless, studies
that reported beneficial results of vagus nerve stimulation on
inflammation have performed stimulation before or simultaneous
to the inflammatory stimulus/insult [10–13,15–18,34–36]. Inter-
estingly, a very recent investigation describes the effects of vagus
nerve stimulation performed 4 hours after induction of polymi-
crobial sepsis by cecal ligation and puncture (CLP) and found no
reduction of lung injury or pulmonary and systemic inflammatory
markers [37]. In agreement, the acetylcholinesterase inhibitor
physostigmine, which reinforces the cholinergic anti-inflammatory
pathway by increasing ACh availability, attenuated inflammation
and septic shock when administered before CLP induction, but not
when administered 6 hours afterwards [38], indicating that the
timing of stimulation of the cholinergic anti-inflammatory pathway
is critical.
In conclusion, this study demonstrates no beneficial effects of
vagus nerve stimulation on systemic or pulmonary inflammation in
a two-hit model in rats where stimulation was performed at a
clinically relevant time point: following the initial hit but before
initiation of MV. This questions the clinical applicability of
stimulation of the cholinergic anti-inflammatory pathway in
systemically inflamed patients admitted to the ICU where MV is
initiated.
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